Supplementary Figure S2 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study

Supplementary Figure S2 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study

<p>Figure S2. Nomogram for predicting progression-free survival (PFS) based on t.TRPC and disease volume score.</p>

Guardat en:

Dades bibliogràfiques
Autor principal:	Ruiliang Wang (17333340) (author)
Altres autors:	Jing Xu (22749676) (author), Chenyi Zhu (22749679) (author), Wujianhong Liu (22749682) (author), Chengqi Jin (22749685) (author), Wentao Luo (22749688) (author), Tingting Zhao (17333385) (author), Changcheng Guo (17333361) (author), Wei Chen (22749691) (author), Bin Yang (17333400) (author)
Publicat:	2025
Matèries:	Cancer Cancer Detection and Diagnosis Methods and Technology Biomarkers Circulating tumor cells/DNA/exosomes Genitourinary Cancers Liquid Biopsy Prostate Cancer
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars

Figure 1 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
per: Ruiliang Wang (17333340)
Publicat: (2025)

Figure 2 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
per: Ruiliang Wang (17333340)
Publicat: (2025)

Figure 3 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
per: Ruiliang Wang (17333340)
Publicat: (2025)

Figure 4 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
per: Ruiliang Wang (17333340)
Publicat: (2025)

Figure 5 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
per: Ruiliang Wang (17333340)
Publicat: (2025)

Figure 6 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
per: Ruiliang Wang (17333340)
Publicat: (2025)

Table 1 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
per: Ruiliang Wang (17333340)
Publicat: (2025)

Supplementary Figure S1 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
per: Ruiliang Wang (17333340)
Publicat: (2025)

Supplementary Figure S3 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
per: Ruiliang Wang (17333340)
Publicat: (2025)

Supplementary Figure S4 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
per: Ruiliang Wang (17333340)
Publicat: (2025)

Supplementary Table S1 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
per: Ruiliang Wang (17333340)
Publicat: (2025)

Supplementary Table S2 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
per: Ruiliang Wang (17333340)
Publicat: (2025)

Supplementary Table S3 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
per: Ruiliang Wang (17333340)
Publicat: (2025)

Supplementary Table S4 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
per: Ruiliang Wang (17333340)
Publicat: (2025)

Supplementary Table S5 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
per: Ruiliang Wang (17333340)
Publicat: (2025)

Supplementary Table S1 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
per: Sofie H. Tolmeijer (15313251)
Publicat: (2025)

Supplementary Table S2 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
per: Sofie H. Tolmeijer (15313251)
Publicat: (2025)

Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
per: Sofie H. Tolmeijer (15313251)
Publicat: (2025)

Supplementary Table S1 from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
per: Navonil De Sarkar (15030509)
Publicat: (2025)

Supplementary Table S2 from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
per: Navonil De Sarkar (15030509)
Publicat: (2025)

Supplementary Table S3 from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
per: Navonil De Sarkar (15030509)
Publicat: (2025)

Supplementary Table S4 from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
per: Navonil De Sarkar (15030509)
Publicat: (2025)

Supplementary Table S5 from Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
per: Navonil De Sarkar (15030509)
Publicat: (2025)

Supplementary Data 1 from Unique Spectrum of Activating <i>BRAF</i> Alterations in Prostate Cancer
per: Alex Chehrazi-Raffle (17079582)
Publicat: (2025)

Supplementary Figure 1 from Unique Spectrum of Activating <i>BRAF</i> Alterations in Prostate Cancer
per: Alex Chehrazi-Raffle (17079582)
Publicat: (2025)

Figure 1 from PSA Secretion from Single Circulating Tumor Cells of Metastatic Castration-Naïve Prostate Cancer Patients
per: Eshwari Dathathri (22071316)
Publicat: (2025)

Figure 2 from PSA Secretion from Single Circulating Tumor Cells of Metastatic Castration-Naïve Prostate Cancer Patients
per: Eshwari Dathathri (22071316)
Publicat: (2025)

Figure 3 from PSA Secretion from Single Circulating Tumor Cells of Metastatic Castration-Naïve Prostate Cancer Patients
per: Eshwari Dathathri (22071316)
Publicat: (2025)

Figure 4 from PSA Secretion from Single Circulating Tumor Cells of Metastatic Castration-Naïve Prostate Cancer Patients
per: Eshwari Dathathri (22071316)
Publicat: (2025)

Figure 5 from PSA Secretion from Single Circulating Tumor Cells of Metastatic Castration-Naïve Prostate Cancer Patients
per: Eshwari Dathathri (22071316)
Publicat: (2025)

Figure 6 from PSA Secretion from Single Circulating Tumor Cells of Metastatic Castration-Naïve Prostate Cancer Patients
per: Eshwari Dathathri (22071316)
Publicat: (2025)

Figure 7 from PSA Secretion from Single Circulating Tumor Cells of Metastatic Castration-Naïve Prostate Cancer Patients
per: Eshwari Dathathri (22071316)
Publicat: (2025)

Table 1 from PSA Secretion from Single Circulating Tumor Cells of Metastatic Castration-Naïve Prostate Cancer Patients
per: Eshwari Dathathri (22071316)
Publicat: (2025)

Figure 1 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
per: Martin Sjöström (14845882)
Publicat: (2025)

Figure 2 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
per: Martin Sjöström (14845882)
Publicat: (2025)

Figure 3 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
per: Martin Sjöström (14845882)
Publicat: (2025)

Figure 4 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
per: Martin Sjöström (14845882)
Publicat: (2025)

Figure 5 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
per: Martin Sjöström (14845882)
Publicat: (2025)

Figure 6 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
per: Martin Sjöström (14845882)
Publicat: (2025)

Figure 7 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
per: Martin Sjöström (14845882)
Publicat: (2025)